1. Home
  2. CHWY vs SNN Comparison

CHWY vs SNN Comparison

Compare CHWY & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chewy Inc.

CHWY

Chewy Inc.

HOLD

Current Price

$34.79

Market Cap

14.2B

ML Signal

HOLD

Logo Smith & Nephew SNATS Inc.

SNN

Smith & Nephew SNATS Inc.

HOLD

Current Price

$33.24

Market Cap

14.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHWY
SNN
Founded
2010
1856
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.2B
14.0B
IPO Year
2019
1999

Fundamental Metrics

Financial Performance
Metric
CHWY
SNN
Price
$34.79
$33.24
Analyst Decision
Strong Buy
Hold
Analyst Count
24
4
Target Price
$45.14
$32.83
AVG Volume (30 Days)
7.1M
583.8K
Earning Date
12-10-2025
10-30-2025
Dividend Yield
N/A
2.20%
EPS Growth
N/A
59.91
EPS
0.35
0.56
Revenue
$12,345,235,000.00
$5,944,000,000.00
Revenue This Year
$8.72
$7.85
Revenue Next Year
$7.87
$5.43
P/E Ratio
$99.54
$28.67
Revenue Growth
9.17
5.35
52 Week Low
$29.83
$23.69
52 Week High
$48.62
$38.79

Technical Indicators

Market Signals
Indicator
CHWY
SNN
Relative Strength Index (RSI) 52.30 42.94
Support Level $31.16 $31.95
Resistance Level $34.98 $33.56
Average True Range (ATR) 1.31 0.40
MACD 0.24 0.10
Stochastic Oscillator 94.20 77.42

Price Performance

Historical Comparison
CHWY
SNN

About CHWY Chewy Inc.

Chewy is the largest e-commerce petcare retailer in the US, generating $11.9 billion in fiscal 2024 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a stand-alone company in 2019 after spending a couple of years developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods like crates, leashes, and bowls.

About SNN Smith & Nephew SNATS Inc.

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Share on Social Networks: